Parkinsonian Disorders: all 218 studies
Page 2 of 3. Open to participants first (63), then studies with results posted, then the rest; newest registration first within each.
- Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PDCompletedNCT05819359Phase 2
- Adipose-derived Stromal Vascular Fraction Cells to Treat ParkinsonCompletedNCT05699161Phase 1/2
- Biomarker Validation Following Sargramostim Treatment in Parkinson's DiseaseCompletedNCT05677633Phase 1
- Unstructured Eye Tracking as a Diagnostic and Prognostic Biomarker in Parkinsonian DisordersStatus unknownNCT05638477Not applicable
- Multiple-dose Trial to Determine the Clinical Bioequivalence Between Tavapadon Tablets in Participants With Parkinson's DiseaseCompletedNCT05610189Phase 1
- External vs Internal-triggered Augmented-reality Visual Cues to Treat Freezing of GaitCompletedNCT05608915Not applicable
- The Calgary Movement Disorders Advanced Care Pilot ProgramStatus unknownNCT05599659Not applicable
- Head-up Tilt Sleeping to Alleviate Orthostatic Hypotension, Supine Hypertension and Nocturia in Parkinson's DiseaseActive, not recruitingNCT05551377Not applicable
- Intensive Multidisciplinary Rehabilitation and Biomarkers in Parkinson's DiseaseStatus unknownNCT05452655Not applicable
- Frailty and Cognitive Function in Parkinson's Disease.CompletedNCT05388526
- Oral Health, Orofacial Function and Oral Health Care in Patients With Parkinson's DiseaseCompletedNCT05356845
- Parkinson's Disease in Home Rehabilitation ServicesCompletedNCT05340283
- Saliva and Extracellular Vesicles for Parkinson's DiseaseCompletedNCT05320250
- Events Exposure as a Trigger of the Clinical Manifestations of Parkinson's DiseaseStatus unknownNCT05308485
- Community Outreach for Palliative Engagement -- Parkinson DiseaseActive, not recruitingNCT05222386Not applicable
- Diaphragmatic Thickness and Pulmonary Function in Parkinson's DiseaseCompletedNCT05194748
- Proactive and Integrated Management and Empowerment in Parkinson's Disease (PRIME-UK): A New Model of Care (PRIME-RCT)CompletedNCT05127057Not applicable
- Multicenter Study of Blood Biomarkers of Mitochondrial and Peroxisomal Metabolism to Differentiate Idiopathic Parkinson's Disease From Related ConditionsStatus unknownNCT05110547
- The Personalized Parkinson Project De Novo CohortActive, not recruitingNCT04985539
- Movement Disorders Analysis Using a Deep Learning ApproachCompletedNCT04974034
- Effects of Music Beat on Motor Function in Individuals At Risk for Psychotic Onset and Schizophrenia PatientsCompletedNCT04929795Not applicable
- Self-Reports of Executive Functions in Persons With Parkinson's Disease and Their Significant OthersStatus unknownNCT04928027
- Complex Eye Movements in Parkinson's Disease and Related Movement DisordersCompletedNCT04925622
- Potential Use of Autologous and Allogeneic Mesenchymal Stem Cells in Patients With Multiple System AtrophyStatus unknownNCT04876326Not applicable
- Role and Mechanism of Probiotics in Improving Motor Symptoms in Mild to Moderate Parkinson's DiseaseStatus unknownNCT04871464Phase 4
- GentleCath Air (Urinary Self-catheterization) - Pain in Female Patients With Neurological Vesico-sphincter DisordersWithdrawnNCT04847609
- Open-label Trial in Parkinson's Disease (PD)CompletedNCT04760769Phase 3
- Linac FRACtionated Radiosurgical THALamotomie in Tremors (FRACTHAL)TerminatedNCT04727658Phase 2
- A Study of Equfina® on the Incidences of Adverse Drug Reactions in Participants With Parkinson's Disease (Including Participants With Hepatic Impairment)CompletedNCT04724109
- Effects of Lactobacillus Plantarum PS128 on Symptoms of Early-onset Parkinson's Disease: a Pilot StudyStatus unknownNCT04722198Not applicable
- Latest Imaging SPECT System Evaluation Phase 1CompletedNCT04704349Not applicable
- LRRK2, GBA and Other Genetic Biomarkers in Eastern European (Ashkenazi) Jews With and Without Parkinson's DiseaseCompletedNCT04668898
- Effects of Rhythmic Auditory Stimulation on Movements in Individuals at Risk for Psychotic Onset and Schizophrenia PatientsStatus unknownNCT04553835Not applicable
- Misfolded Proteins in the Skin of People With Parkinson's Disease and Other ParkinsonismCompletedNCT04518059
- Optimizing BCI-FIT: Brain Computer Interface - Functional Implementation ToolkitCompletedNCT04468919Not applicable
- Cerebellar rTMS Theta Burst for Dual-task Walking in Parkinson's DiseaseStatus unknownNCT04238000Not applicable
- tDCS Plus Physical Therapy for Progressive Supranuclear PalsyCompletedNCT04237948Not applicable
- Long-Term Follow-up Safety After DDS Implantation With/Without CDNF InfusionsStatus unknownNCT04228653Phase 1/2
- Cerebellar rTMS Theta Burst for Postural Instability in Progressive Supranuclear PalsyCompletedNCT04222218Not applicable
- LIPAD - LRRK2 International Parkinson's Disease StudyStatus unknownNCT04214509
- A Pilot Study to Explore the Role of Gut Flora in Parkinson's DiseaseWithdrawnNCT04148326
- Effects of Transcranial Direct Current Stimulation (tDCS) on Motor Function in Schizophrenia Patients and Individuals at Risk for Psychotic OnsetStatus unknownNCT04086160Not applicable
- PDGeneration: Mapping the Future of Parkinson's DiseaseActive, not recruitingNCT04057794Not applicable
- Dual-task Performance in Young-onset PDStatus unknownNCT04033393Not applicable
- Trial of Parkinson's And Zoledronic AcidCompletedNCT03924414Phase 4
- Neurology Inpatient Clinical Education TrialCompletedNCT03826056Not applicable
- rTMS Treatment in Vascular ParkinsonismWithdrawnNCT03720691Not applicable
- Imaging Neuromelanin and Iron in Dystonia/ParkinsonismStatus unknownNCT03572114
- Improving Posture in Parkinson's Patients Through Home-based Training and BiofeedbackStatus unknownNCT03477695Not applicable
- Combined Stimulation of STN and SNr for Dysphagia in Parkinson's DiseaseStatus unknownNCT03470324Not applicable
- A Study Into the Underlying Biochemical Pathways Involved in Parkinson's Disease, Such as Mitochondrial (Cellular "Powerhouse") DysfunctionCompletedNCT03421899
- Novel Neuroimage Study in Tauopathies With ParkinsonismCompletedNCT03386669Phase 2
- Effects of a Dance and Walking Program for People With Parkinson's DiseaseCompletedNCT03370315Not applicable
- Effect of Need to Void on Parkinsonian GaitCompletedNCT03314610
- Brain Network Activation in Patients With Movement DisordersStatus unknownNCT03269201
- Alpha-synuclein Level in Saliva to Differentiate Between Idiopathic Parkinson Disease and Iatrogenic Parkinsonian SyndromeCompletedNCT03156647
- West Sweden Parkinson Objective Measurement Registry StudyActive, not recruitingNCT03130595
- More Than a Movement Disorder: Applying Palliative Care to Parkinson's DiseaseCompletedNCT03076671Not applicable
- Trial of OnabotulinumtoxinA for Depression in Parkinson DiseaseTerminatedNCT03069911Phase 1
- Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's DiseaseCompletedNCT03065192Phase 1
- A Randomized, Double-Blind, Placebo-Controlled Study of Droxidopa for Fatigue in Parkinson's DiseaseTerminatedNCT03034564Phase 4
- An Open-Label Tolerability and Exploratory Efficacy Study of Zonisamide for Dyskinesias in Parkinson's DiseaseSuspendedNCT03034538Phase 4
- Clinical and Physiological Studies of Tremor SyndromesCompletedNCT03027310
- Gait Analysis in Neurological DiseaseActive, not recruitingNCT02994719
- Mobile Parkinson Observatory for Worldwide, Evidence-based Research (mPower)Active, not recruitingNCT02696603Not applicable
- Non-motor Symptoms and Brain Dopamine Transporter BindingActive, not recruitingNCT02650843
- Hereditary Parkinson s Disease Natural History ProtocolCompletedNCT02511015
- To Study the Efficacy of Bromocriptine in Patients With Hepatic/Cirrhosis Related ParkinsonismCompletedNCT02265484Not applicable
- Exercise, Brain Imaging, Cognition, and Gait in ParkinsonismCompletedNCT02231073Not applicable
- 2-(1-{6-[(2-[F-18]Fluoroethyl) (Methyl)Amino]-2-naphthyl} Ethylidene) Malononitrile-PET for in Vivo Diagnose of Tauopathy in Unclassified ParkinsonismCompletedNCT02214862Early Phase 1
- 18F-DTBZ PET and Multi-modal MRI in the Patients With Vascular ParkinsonismCompletedNCT02195154Phase 2
- Targeting Monoaminergic Neuronal Networks in the Parkinsonian Patients After Carbon Monoxide IntoxicationStatus unknownNCT02138864Phase 3
- Measurement of Gait Using Opal APDM and Gait Mat in ParkinsonismCompletedNCT02064543
- BEWARE: Body Awareness Training in the trEatment of Wearing-off Related Anxiety in Patients With paRkinson's DiseaseStatus unknownNCT02054845Not applicable
- Post-prandial Hypotension and Sleepiness in Parkinson's Disease and Other SynucleinopathiesCompletedNCT02021903Not applicable
- Parkinsonism in Spinocerebellar Ataxia Type 6CompletedNCT01934998
- Identifying Biomarkers of Parkinson's Disease Using Magnetic Resonance Imaging (MRI)CompletedNCT01888185
- Repetitive Transcranial Magnetic Stimulation for Freezing of GaitCompletedNCT01853150Not applicable
- Pilot Study To Assess Effect of Treatment and Adherence in PD SubjectsCompletedNCT01788696Phase 1
- Diagnosis of Parkinson's Disease Using Diffusion Magnetic Resonance ImagingCompletedNCT01715727
- Effect of Undenatured Cysteine-Rich Whey Protein Isolate (HMS 90®) in Patients With Parkinson's DiseaseCompletedNCT01662414Phase 4
- Mobilaser Study to Help With People Who Are Having Problems With Their GaitCompletedNCT01581645Early Phase 1
- Mutations Associated With Parkinson s DiseaseTerminatedNCT01547832
- Imaging Biomarkers in Parkinson s DiseaseCompletedNCT01496599
- Open-label, Long-term Safety Extension Study of AFQ056 in Parkinson's Patients With L-dopa Induced DyskinesiasCompletedNCT01491932Phase 2
- Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced DyskinesiasCompletedNCT01491529Phase 2
- Evaluation of the Efficacy and Safety of AFQ056 in Parkinson's Patients With L-dopa Induced DyskinesiasCompletedNCT01385592Phase 2
- Molecular Analysis of Human Neural Stem CellsWithdrawnNCT01329926
- Study to Determine Mutations in the Gaucher Gene in Patients With Idiopathic Parkinson's Disease for Phenotype-genotype CorrelationCompletedNCT01272687
- Exploratory Study Using Nanotechnology to Detect Biomarkers of Parkinson's Disease From Exhaled BreathCompletedNCT01246336
- Caffeine for Motor Manifestations of Parkinson's DiseaseCompletedNCT01190735Phase 2
- Repetitive Transcranial Magnetic Stimulation (TMS) for Progressive Supranuclear Palsy and Corticobasal DegenerationCompletedNCT01174771
- Amantadine for Improving Neurologic Symptoms in Ataxia-TelangiectasiaCompletedNCT00950196Phase 4
- Treating Sleep/Wake Cycle Disturbances in Basal Ganglia Disorders With RamelteonWithdrawnNCT00907595Not applicable
- RBD Longitudinal as Prognostic for PDActive, not recruitingNCT00817726
- Botulinum Toxin for Treatment of Seborrhic Dermatitis in Parkinsonian PatientsStatus unknownNCT00767546Phase 1
- Two Separate But Identical Studies Evaluating the Safety and Efficacy of ALTROPANE® in the Use of SPECT Imaging for Upper Extremity TremorStatus unknownNCT00724906Phase 3
- Studies of the Variable Phenotypic Presentations of Rapid-Onset Dystonia Parkinsonism and Other Movement DisordersActive, not recruitingNCT00682513
- Study of AAV-GAD Gene Transfer Into the Subthalamic Nucleus for Parkinson's DiseaseTerminatedNCT00643890Phase 2
- Transcranial Duplex Scanning and Single Photon Emission Computer Tomography (SPECT) in Parkinsonian SyndromesCompletedNCT00368199